Vice Provost and Dean of Research
Showing 101-196 of 196 Results
-
Paul McIntyre
Rick and Melinda Reed Professor, Professor of Photon Science and Senior Fellow at the Precourt Institute for Energy
BioMcIntyre's group performs research on nanostructured inorganic materials for applications in electronics, energy technologies and sensors. He is best known for his work on metal oxide/semiconductor interfaces, ultrathin dielectrics, defects in complex metal oxide thin films, and nanostructured Si-Ge single crystals. His research team synthesizes materials, characterizes their structures and compositions with a variety of advanced microscopies and spectroscopies, studies the passivation of their interfaces, and measures functional properties of devices.
-
David B. McKay
Professor of Structural Biology, Emeritus
Current Research and Scholarly InterestsThree-dimensional structure determination and biophysical studies of macromolecules.
-
Tracey McLaughlin
Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets
-
Uel Jackson McMahan
Professor of Neurobiology and of Structural Biology, Emeritus
Current Research and Scholarly InterestsWe are currently investigating mechanisms involved in synaptic transmission and synaptogenesis using electron microscope tomography in ways that provide in situ 3D structural information at macromolecular resolution.
-
Jennifer A McNab
Associate Professor (Research) of Radiology (Radiological Sciences Laboratory)
Current Research and Scholarly InterestsMy research is focused on developing magnetic resonance imaging (MRI) methods that probe brain tissue microstructure. This requires new MRI contrast mechanisms, strategic encoding and reconstruction schemes, physiological monitoring, brain tissue modeling and validation. Applications of these methods include neuronavigation, neurosurgical planning and the development of improved biomarkers for brain development, degeneration, disease and injury.
-
Kimford Meador, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
BioDr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center. Dr. Meador graduated from the Georgia Institute of Technology in Applied Biology (with high honor) and received his MD from the Medical College of Georgia. After an internship at the University of Virginia and service as an officer in the Public Health Corps, he completed a residency in Neurology at the Medical College of Georgia and a fellowship in Behavioral Neurology at the University of Florida. Dr. Meador joined the faculty at the Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was the Chair of Neurology at Georgetown University (2002-2004), the Melvin Greer Professor of Neurology and Neuroscience at the University of Florida (2004-2008) where he served as Director of Epilepsy Program and Director of the Clinical Alzheimer Research Program, and Professor of Neurology and Pediatrics at Emory University (2008-2013) where he served as Director of Epilepsy and of Clinical Neurocience Research. He joined the faculty of Stanford University in 2013. Dr. Meador has authored over 400 peer-reviewed publications. His research interests include: cognitive mechanisms (e.g., memory and attention); cerebral lateralization; pharmacology and physiology of cognition; mechanisms of perception, consciousness and memory; EEG; epilepsy; epilepsy and pregnancy; preoperative evaluation for epilepsy surgery; intracarotid amobarbital procedure (i.e., Wada test); functional imaging; therapeutic drug trials; neurodevelopmental effects of antiepileptic drugs; psychoimmunology; behavioral disorders (e.g., aphasia, neglect, dementia); and neuropsychiatric disorders. Dr. Meador has served as the PI for a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Dr. Meador has served on the editorial boards for Clinical Neurophysiology, Epilepsy and Behavior, Epilepsy Currents, Journal of Clinical Neurophysiology, Neurology, Cognitive and Behavioral Neurology, and Epilepsy.com. His honors include Resident Teaching Award Medical College of Georgia; Outstanding Young Faculty Award in Clinical Sciences Medical College of Georgia; Distinguished Faculty Award for Clinical Research Medical College of Georgia Lawrence C. McHenry History Award American Academy of Neurology; Dreifuss Abstract Award American Epilepsy Society; Fellow of the American Neurological Association; Diplomat of American Neurologic Association; past Chair of the Section of Behavioral Neurology of American Academy of Neurology; past President of Society for Cognitive and Behavioral Neurology; past President of the Society for Behavioral & Cognitive Neurology; past President of the Southern EEG & Epilepsy Society; ranking in the top 10 experts in epilepsy worldwide by Expertscape; Distinguished Alumnus Award for Professional Achievement, Medical College of Georgia, Georgia Regents University 2015; American Epilepsy Society Clinical Research Award; and named award by the American Epilepsy Society: “Kimford J. Meador Research in Women with Epilepsy Award,” and ranked in the top 500 neuroscientist in the world and top 300 in USA by Research.com in 2022.
-
Caroline Meinhardt
Policy Research Manager, Institute for Human-Centered Artificial Intelligence (HAI)
BioCaroline Meinhardt is a policy research manager at the Stanford Institute for Human-Centered Artificial Intelligence (HAI), where she manages the institute's policy research initiatives. Her research focuses on the implementation challenges of AI regulation, the governance of large-scale AI models, healthcare AI policy, and global AI governance approaches. Prior to joining HAI, she worked as a China-focused consultant and analyst, delivering in-depth research and strategic advice regarding China’s development and regulation of emerging technologies, including AI. She holds a Master's in International Policy from Stanford University and a Bachelor's in Chinese Studies from the University of Cambridge.
-
Elizabeth Mellins
Member, Bio-X
Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.
-
Nicholas Melosh
Professor of Materials Science and Engineering
BioThe Melosh group explores how to apply new methods from the semiconductor and self-assembly fields to important problems in biology, materials, and energy. We think about how to rationally design engineered interfaces to enhance communication with biological cells and tissues, or to improve energy conversion and materials synthesis. In particular, we are interested in seamlessly integrating inorganic structures together with biology for improved cell transfection and therapies, and designing new materials, often using diamondoid molecules as building blocks.
My group is very interested in how to design new inorganic structures that will seamless integrate with biological systems to address problems that are not feasible by other means. This involves both fundamental work such as to deeply understand how lipid membranes interact with inorganic surfaces, electrokinetic phenomena in biologically relevant solutions, and applying this knowledge into new device designs. Examples of this include “nanostraw” drug delivery platforms for direct delivery or extraction of material through the cell wall using a biomimetic gap-junction made using nanoscale semiconductor processing techniques. We also engineer materials and structures for neural interfaces and electronics pertinent to highly parallel data acquisition and recording. For instance, we have created inorganic electrodes that mimic the hydrophobic banding of natural transmembrane proteins, allowing them to ‘fuse’ into the cell wall, providing a tight electrical junction for solid-state patch clamping. In addition to significant efforts at engineering surfaces at the molecular level, we also work on ‘bridge’ projects that span between engineering and biological/clinical needs. My long history with nano- and microfabrication techniques and their interactions with biological constructs provide the skills necessary to fabricate and analyze new bio-electronic systems.
Research Interests:
Bio-inorganic Interface
Molecular materials at interfaces
Self-Assembly and Nucleation and Growth -
Teresa Meng
Reid Weaver Dennis Professor in Electrical Engineering and Professor of Computer Science, Emerita
BioTeresa H. Meng is the Reid Weaver Dennis Professor of Electrical Engineering, Emerita, at Stanford University. Her research activities in the first 10 years focused on low-power circuit and system design, video signal processing, and wireless communications. In 1998, Prof. Meng took leave from Stanford and founded Atheros Communications, Inc., which developed semiconductor system solutions for wireless network communications products. After returning to Stanford in 2000 to continue her teaching and research, Prof. Meng turned her research interest to applying signal processing and IC design to bio-medical engineering. She collaborated with Prof. Krishna Shenoy on neural signal processing and neural prosthetic systems. She also directed a research group exploring wireless power transfer and implantable bio-medical devices. Prof. Meng retired from Stanford in 2013.
-
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
On Partial Leave from 12/16/2025 To 03/15/2026Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Chris Mentzel
Managing Director of Research and Campus Engagement, Institute for Human-Centered Artificial Intelligence (HAI)
BioChris leads Stanford’s efforts in research and early-career development around data science and data-driven discovery, engaging the entire campus in advancing and applying new data science and AI theory and practice to accelerate research.
Previously, Chris started and led the Moore Foundation's Data-Driven Discovery Initiative, an $80 million effort within the Science Program to enable data scientists to turn the scientific data deluge into opportunities to address some of today's most important research questions. He also led the grants administration department and worked as senior network engineer for the foundation. Chris has held positions as a systems engineer and integrator at the University of California, Berkeley, and at various Internet consulting firms in the Bay Area. An active member of the broader big data and open science communities, Chris serves on a number of advisory boards and program committees and speaks frequently at conferences and workshops on topics related to data-driven research.
Chris received a B.A. in mathematics from the University of California, Santa Cruz, and an M.Sc. in management science and engineering at Stanford University. -
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Everett Meyer
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy), of Pediatrics (Stem Cell Transplantation) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Inger Hultgren Meyer
Sr. Industrial Contracts Officer, Office of Technology Licensing (OTL)
BioInger is a Senior Industrial Contracts Officer in the Industrial Contracts Office within Stanford’s Office of Technology Licensing. She has over 14 years of experience as a lawyer at law firms and companies in the technology, health care, and consumer products industries in the U.S. and Europe. Before joining Stanford, Inger was an Associate General Counsel at Meta Platforms, Inc. where she advised Meta’s research and engineering teams on IP and other issues arising out of academic collaborations and drafted and negotiated a variety of complex academic collaboration agreements with university partners. Inger holds a B.A. in Government from Cornell University and a J.D. from George Washington University Law School.
-
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
-
Sara Michie
Professor of Pathology (Research), Emerita
Current Research and Scholarly InterestsLymphocyte/endothelial cell adhesion mechanisms involved in lymphocyte migration to sites of inflammation; regulation of expression of endothelial cell adhesion molecules.
-
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.
-
Paul Milgrom
Shirley R. and Leonard W. Ely, Jr. Professor in the School of Humanities and Sciences, Professor of Economics, Senior Fellow at SIEPR and Professor, by courtesy, of Economics at the GSB and of Management Science and Engineering
BioPaul Milgrom is the Shirley and Leonard Ely professor of Humanities and Sciences in the Department of Economics at Stanford University and professor, by courtesy, in the Stanford Graduate School of Business and in the Department of Management Sciences and Engineering. Born in Detroit, Michigan on April 20, 1948, he is a member of both the National Academy of Sciences and the American Academy of Arts and Sciences and a winner of the 2008 Nemmers Prize in Economics, the 2012 BBVA Frontiers of Knowledge award, the 2017 CME-MSRI prize for Innovative Quantitative Applications, and the 2018 Carty Award for the Advancement of Science.
Milgrom is known for his work on innovative resource allocation methods, particularly in radio spectrum. He is coinventor of the simultaneous multiple round auction and the combinatorial clock auction. He also led the design team for the FCC's 2017 incentive auction, which reallocated spectrum from television broadcast to mobile broadband.
According to his BBVA Award citation: “Paul Milgrom has made seminal contributions to an unusually wide range of fields of economics including auctions, market design, contracts and incentives, industrial economics, economics of organizations, finance, and game theory.” As counted by Google Scholar, Milgrom’s books and articles have received more than 80,000 citations.
Finally, Milgrom has been a successful adviser of graduate students, winning the 2017 H&S Dean's award for Excellence in Graduate Education. -
Carlos Milla
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsAt Stanford University I developed and currently direct the CF Translational Research Center. The overarching goal of the center is to provide the groundwork to streamline, accelerate, and promote the translation of basic discoveries into effective therapies and interventions to benefit patients affected by cystic fibrosis. My laboratory group currently has three main lines of investigation: respiratory cell biology in CF; remote biochemical monitoring; and lung physiology in young children.
-
D. Craig Miller, M.D.
Thelma and Henry Doelger Professor of Cardiovascular Surgery, Emeritus
Current Research and Scholarly InterestsCardiac and heart valve disease with experimental laboratory large animal projects focused on the investigation of left ventricular and cardiac mechanics, bioenergetics, and LV and mitral valve physiology and pathophysiology. Current thrust is aimed at understanding the mitral valve and subvalvular mitral apparatus and transmural LV wall strains, thickening, and myolaminar fiber-sheet mechanics.
Clinical research interests include thoracic aortic diseases (aortic dissection, aneurysm) and cardiac valvular disease, including surgical treatment, endovascular thoracic aortic stent-graft repair, mitral valve repair, and valve-sparing aortic root replacement. -
Arnold Milstein
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly InterestsDesign national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.
Research on creation of a national index of health system productivity gain. -
Paul Salomon Mischel
Fortinet Founders Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research bridges cancer genetics, signal transduction and cellular metabolism as we aim to understand the molecular mechanisms that drive cancer development, progression, and drug resistance. We have made a series of discoveries that have identified a central role for ecDNA (extrachromosomal DNA) in cancer development, progression, accelerated tumor evolution and drug resistance.
-
William Mitch
Professor of Civil and Environmental Engineering
BioBill Mitch received a B.A. in Anthropology (Archaeology) from Harvard University in 1993. During his studies, he excavated at Mayan sites in Belize and surveyed sites dating from 2,000 B.C. in Louisiana. He switched fields by receiving a M.S. degree in Civil and Environmental Engineering at UC Berkeley. He worked for 3 years in environmental consulting, receiving his P.E. license in Civil Engineering in California. Returning to UC Berkeley in 2000, he received his PhD in Civil and Environmental Engineering in 2003. He moved to Yale as an assistant professor after graduation. His dissertation received the AEESP Outstanding Doctoral Dissertation Award in 2004. At Yale, he serves as the faculty advisor for the Yale Student Chapter of Engineers without Borders. In 2007, he won a NSF CAREER Award. He moved to Stanford University as an associate professor in 2013.
Employing a fundamental understanding of organic chemical reaction pathways, his research explores links between public health, engineering and sustainability. Topics of current interest include:
Public Health and Emerging Carcinogens: Recent changes to the disinfection processes fundamental to drinking and recreational water safety are creating a host of highly toxic byproducts linked to bladder cancer. We seek to understand how these compounds form so we can adjust the disinfection process to prevent their formation.
Global Warming and Oceanography: Oceanic dissolved organic matter is an important global carbon component, and has important impacts on the net flux of CO2 between the ocean and atmosphere. We seek to understand some of the important abiotic chemical reaction pathways responsible for carbon turnover.
Sustainability and Persistent Organic Pollutants (POPs): While PCBs have been banned in the US, we continue to produce a host of structurally similar chemicals. We seem to understand important chemical pathways responsible for POP destruction in the environment, so we can design less persistent and problematic chemicals in the future.
Engineering for Sustainable Wastewater Recycling: The shortage of clean water represents a critical challenge for the next century, and has necessitated the recycling of wastewater. We seek to understand ways of engineer this process in ways to minimize harmful byproduct formation.
Carbon Sequestration: We are evaluating the formation of nitrosamine and nitraminecarcinogens from amine-based carbon capture, as well as techniques to destroy any of these byproducts that form. -
John Mitchell
Mary and Gordon Crary Family Professor in the School of Engineering, and Professor, by courtesy, of Electrical Engineering and of Education
Current Research and Scholarly InterestsProgramming languages, computer security and privacy, blockchain, machine learning, and technology for education
-
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Subhasish Mitra
William E. Ayer Professor of Electrical Engineering and Professor of Computer Science
BioSubhasish Mitra holds the William E. Ayer Endowed Chair Professorship in the Departments of Electrical Engineering and Computer Science at Stanford University. He directs the Stanford Robust Systems Group, serves on the leadership team of the Microelectronics Commons AI Hardware Hub funded by the US CHIPS and Science Act, leads the Computation Focus Area of the Stanford SystemX Alliance, and is the Associate Chair (Faculty Affairs) of Computer Science. His research ranges across Robust Computing, NanoSystems, Electronic Design Automation (EDA), and Neurosciences. Results from his research group have influenced almost every contemporary electronic system and have inspired significant government and research initiatives in multiple countries. He has held several international academic appointments — the Carnot Chair of Excellence in NanoSystems at CEA-LETI in France, Invited Professor at EPFL in Switzerland, and Visiting Professor at the University of Tokyo in Japan. Prof. Mitra also has consulted for major technology companies including AMD (XIlinx), Cisco, Google, Intel, Merck (EMD Electronics), and Samsung.
In the field of Robust Computing, he has created many key approaches for circuit failure prediction, CASP on-line diagnostics, QED system validation, soft error resilience, and X-Compact test compression. Their adoption by industry is growing rapidly, in markets ranging from cloud computing to automotive systems, under various names (Silicon Lifecycle Management, Predictive Health Monitoring, In-System Test Architecture, In-field Scan, In-fleet Scan). His X-Compact approach has proven essential to cost-effective manufacturing and high-quality testing of almost all 21st century systems. X-Compact and its derivatives enabled billions of dollars of cost savings across the industry.
In the field of NanoSystems, with his students and collaborators, he demonstrated several firsts: the first NanoSystems hardware among all beyond-silicon nanotechnologies for energy-efficient computing (the carbon nanotube computer), the first 3D NanoSystem with computation immersed in data storage, the first published end-to-end computing systems using resistive memories (Resistive RAM-based non-volatile computing systems delivering 10-fold energy efficiency versus embedded flash), and the first monolithic 3D integration combining heterogeneous logic and memory technologies in silicon foundry. These received wide recognition: cover of NATURE, several Highlights to the US Congress, and highlight as "important scientific breakthrough" by news organizations worldwide.
Prof. Mitra's honors include the Harry H. Goode Memorial Award (by IEEE Computer Society for outstanding contributions in the information processing field), Newton Technical Impact Award in EDA (test-of-time honor by ACM SIGDA and IEEE CEDA), the University Researcher Award (by Semiconductor Industry Association and Semiconductor Research Corporation to recognize lifetime research contributions), the EDAA Achievement Award (by European Design and Automation Association, for outstanding lifetime contributions to electronic design, automation and testing), the Intel Achievement Award (Intel’s highest honor), and the Distinguished Alumnus Award from the Indian Institute of Technology, Kharagpur. He and his students have published over 15 award-winning papers across 5 topic areas (technology, circuits, EDA, test, verification) at major venues including the Design Automation Conference, International Electron Devices Meeting, International Solid-State Circuits Conference, International Test Conference, Symposia on VLSI Technology/VLSI Circuits, and Formal Methods in Computer-Aided Design. Stanford undergraduates have honored him several times "for being important to them." He is a Fellow of the Association for Computing Machinery (ACM) and the Institute of Electrical and Electronics Engineers (IEEE), and a Foreign Member of Academia Europaea. -
Daria Mochly-Rosen
George D. Smith Professor of Translational Medicine
Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.
-
Everett J. Moding, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.
-
W. E. Moerner
Harry S. Mosher Professor and Professor, by courtesy, of Applied Physics
Current Research and Scholarly InterestsLaser spectroscopy and microscopy of single molecules to probe biological systems, one biomolecule at a time. Primary thrusts: fluorescence microscopy far beyond the optical diffraction limit (PALM/STORM/STED), methods for 3D optical microscopy in cells, and trapping of single biomolecules in solution for extended study. We explore protein localization patterns in bacteria, structures of amyloid aggregates in cells, signaling proteins in the primary cilium, and dynamics of DNA and RNA.
-
Matteo Amitaba Mole'
Assistant Professor of Obstetrics and Gynecology (Reproductive, Perinatal & Stem Cell Biology Research)
Current Research and Scholarly InterestsWe study how the human embryo implants inside the maternal uterine tissue to establish a healthy pregnancy and the underlying maternal-embryo communication.
-
Denise M. Monack
Martha Meier Weiland Professor in the School of Medicine
Current Research and Scholarly InterestsThe primary focus of my research is to understand the genetic and molecular mechanisms of intracellular bacterial pathogenesis. We use several model systems to study complex host-pathogen interactions in the gut and in immune cells such as macrophages and dendritic cells. Ultimately we would like to understand how Salmonella persists within certain hosts for years in the face of a robust immune response.
-
Benoît Monin
Bowen H. and Janice Arthur McCoy Professor of Leadership Values and Professor of Psychology
BioBenoît Monin received his Ph.D. in Psychology from Princeton University, and an M.Sc. in Social Psychology at the London School of Economics. He completed his undergraduate studies at ESSEC (France). Monin joined the Stanford Department of Psychology in 2001, and since 2008 he has held appointments both in psychology and in the Organizational Behavior area at the Stanford Graduate School of Business.
-
Stephen Monismith
Obayashi Professor in the School of Engineering and Professor of Oceans
Current Research and Scholarly InterestsHydrodynamics of lakes, estuaries, coral reefs, kelp forests and the coastal ocean
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Andrea Montanari
John D. and Sigrid Banks Professor and Professor of Mathematics
BioI am interested in developing efficient algorithms to make sense of large amounts of noisy data, extract information from observations, estimate signals from measurements. This effort spans several disciplines including statistics, computer science, information theory, machine learning.
I am also working on applications of these techniques to healthcare data analytics. -
Maria Emilia Montez Rath
Assistant Professor (Research) of Medicine (Nephrology)
BioDr. Montez-Rath completed her PhD in Biostatistics from Boston University in 2008 focusing on methods for modeling interaction effects in studies involving populations with high levels of comorbidity, such as persons on dialysis. She is a senior biostatistician and director of the Biostatistics Core of the Division of Nephrology at Stanford University where she has been collaborating with faculty and fellows since 2010 to study a variety of research questions relevant to kidney disease. Her methodological interests are mainly data-driven and include the handling of missing data, survival analysis with an emphasis on models for time-varying covariates and competing risks, methods for analyzing epidemiologic studies, analysis of correlated data and comparative effectiveness studies, as well as data visualization.
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Thomas Montine, MD, PhD
Stanford Medicine Professor of Pathology
On Partial Leave from 03/01/2026 To 03/31/2026BioDr. Montine is the Stanford Medicine Endowed Professor, Chair of Stanford Pathology Department, and member of the National Academy of Medicine. He received his education and medical training at Columbia University, McGill University, and Duke University, and was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology at the University of Washington where he was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and founding Director of the Pacific Udall Center, a NINDS-funded Center of Excellence for Parkinson’s Disease Research. Dr. Montine was Chair of the Department of Pathology at the University of Washington from 2010 to 2016 when he was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor.
The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment. The Montine Laboratory addresses this prevalent, unmet medical need through a combination of neuropathology, biomarkers for detection and progression of early disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and then develop novel approaches to neuroprotection. Our current approaches include small molecule precision therapeutics and cell replacement strategies for brain. -
Tirin Moore
Ben Barres Professor
Current Research and Scholarly InterestsWe study neural circuit mechanisms of visual perception, cognition and sensorimotor integration.
-
Kelli Moran-Miller, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Kelli Moran-Miller joined Stanford in Psychiatry & Behavioral Sciences in 2015. She is a licensed psychologist specializing in athlete mental health and sport and performance psychology. She also is a Certified Mental Performance Consultant with the Association of Applied Sport Psychology and a member of the US Olympic Committee registry. In her current role with Stanford Athletics (DAPER), she provides clinical and performance psychology services for varsity student-athletes, coaches, staff, and varsity sport teams. Prior to Stanford, she was the Director of Counseling and Sport Psychology - Athletics at the University of Iowa.
-
Erin Mordecai
Associate Professor of Biology and Senior Fellow at the Woods Institute for the Environment
Current Research and Scholarly InterestsOur research focuses on the ecology of infectious disease. We are interested in how climate, species interactions, and global change drive infectious disease dynamics in humans and natural ecosystems. This research combines mathematical modeling and empirical work. Our main study systems include vector-borne diseases in humans and fungal pathogens in California grasses.
-
Elizabeth Mormino
Associate Professor (Research) of Neurology and Neurological Sciences (Neurology Research)
BioDr. Beth Mormino completed a PhD in Neuroscience at UC Berkeley in the laboratory of Dr. William Jagust, where she performed some of the initial studies applying Amyloid PET with the tracer PIB to clinically normal older individuals. This initial work provided evidence that the pathophysiological processes of Alzheimer’s disease begin years before clinical symptoms and are associated with subtle changes to brain regions critical for memory. During her postdoctoral fellowship with Drs. Reisa Sperling and Keith Johnson at Massachusetts General Hospital she used multimodal imaging techniques to understand longitudinal cognitive changes among individuals classified as preclinical AD. In 2017, Dr. Mormino joined the faculty at Stanford University in the department of Neurology and Neurological Sciences. Her research program focuses on combining imaging and genetics to predict cognitive trajectories over time, and the integration of novel PET scans to better understand human aging and neurodegenerative diseases.
-
Ashby Morrison
Professor of Biology
Current Research and Scholarly InterestsOur research interests are to elucidate the contribution of chromatin to mechanisms that promote genomic integrity.
-
Melanie Morten
Associate Professor of Economics and Senior Fellow at the Stanford Institute for Economic Policy Research
BioPersonal website: www.stanford.edu/~memorten
-
Michael Moseley
Professor of Radiology (Radiological Sciences Lab)
Current Research and Scholarly InterestsMR physics into tissue contrast mechanisms such as diffusion, perfusion, and functional imaging describes the research direction. Applications of cerebral stroke (brain attacks) and neurocognitive disorders are also being developed from these methods
-
Darius M. Moshfeghi, MD
Professor of Ophthalmology
Current Research and Scholarly InterestsDr. Moshfeghi leads the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP network) and the Pediatrix-Stanford collaboration TeleROP. Between these 2 screening programs, nearly 2% of United States neonatal intensive care units are being provided telemedicine screening services through Stanford University.
-
Igor Moskalenko
Sr Res Scientist-Physical
Current Research and Scholarly InterestsParticle/high-energy astrophysics, atomic and nuclear physics. Currently working on models of cosmic-ray production and propagation, particle interactions with fields and matter, search for signatures of dark matter and new physics, analysis of diffuse X- and gamma-ray emission, gamma-ray emission from compact objects, SNRs, and solar system bodies
-
Heather E. Moss, MD, PhD
Professor of Ophthalmology and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsI am a clinician scientist with a background in engineering, epidemiology and neuro-ophthalmology. In my research, I combine tools from these disciplines with the goal of understanding and preventing vision loss from optic nerve diseases. My focus is on papilledema, the swelling of the optic nerve head due to elevation in intracranial pressure, which we are characterizing using electrophysiological and imaging techniques. Other areas of interest are peri-operative vision loss and optic neuritis.
-
Philippe Mourrain
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
BioExpertise: Neurobiology, Sleep sciences, Molecular Genetics, Developmental Biology, Gene Silencing/Epigenetics
Methodology: Synapse Imaging (Two photon microscopy, Array Tomography), Calcium Imaging (Light Sheet Microscopy/SPIM, Light Field Microscopy), Optogenetics, CLARITY, Tol2 transgenesis, TALENs, CRISPR/Cas9, Video tracking and behavior computation. -
Paula M. L. Moya
Danily C. and Laura Louise Bell Professor of the Humanities and Professor, by courtesy, of African and African American Studies and of Iberian and Latin American Cultures
BioMoya is currently the Ellen Andrews Wright Internal Fellow at the Stanford Humanities Center, where she is on leave for AY 2025-2026.
She is the author of The Social Imperative: Race, Close Reading, and Contemporary Literary Criticism (Stanford UP 2016) and Learning From Experience: Minority Identities, Multicultural Struggles (UC Press 2002). She has co-edited three collections of original essays including Doing Race: 21 Essays for the 21st Century (W.W. Norton, Inc. 2010), Identity Politics Reconsidered (Palgrave 2006) and Reclaiming Identity: Realist Theory and the Predicament of Postmodernism (UC Press 2000).
Her teaching and research focus on twentieth-century and early twenty-first century literary studies, feminist theory, critical theory, narrative theory, speculative fiction, interdisciplinary approaches to race and ethnicity, and Chicano/a and U.S. Latina/o studies.
At Stanford, Moya has served as the Faculty Director of the Center for Comparative Studies in Race and Ethnicity (CCSRE), Director of the Research Institute of the Center for Comparative Studies in Race and Ethnicity (CCSRE), Director of the Program of Modern Thought and Literature (MTL), Vice Chair of the Department of English, and the Director of the Undergraduate Program of CCSRE. She has been the faculty coordinator of several faculty-graduate student research networks sponsored by the Stanford Humanities Center, the Research Institute for the Comparative Studies in Race and Ethnicity, and Modern Thought and Literature. They include The Interdisciplinary Working Group in Critical Theory (2015-2016, 2012-2014), Feminist Theory (2007-08, 2002-03), Americanity / Coloniality / Modernity (2006-07), and How Do Identities Matter? (2003-06).
Moya was a co-PI of the Stanford Catalyst Motivating Mobility project, and team leader of the Perfecto Project, a fitness tracking app that combines narrative theory, social psychology, and UI/UX research to leverage culturally-specific narratives and artwork to encourage positive behavior change and healthier living in middle-aged and elderly Latinx populations. She was also a founding organizer and coordinating team member of The Future of Minority Studies research project (FMS), an inter-institutional, interdisciplinary, and multigenerational research project facilitating focused and productive discussions about the democratizing role of minority identity and participation in a multicultural society.
Moya has been a fellow at the Center for Advanced Study in the Behavioral Sciences, a Clayman Institute Fellow, a CCSRE Faculty Research Fellow, and a Ford Foundation posdoctoral fellow. She has also been the recipient of the Dean’s Award for Distinguished Teaching and an Outstanding Chicana/o Faculty Member award. -
Prithvi Mruthyunjaya, MD, MHS
Alan Adler Professor of Ophthalmology and Professor, by courtesy, of Radiation Oncology
Current Research and Scholarly InterestsDr Mruthyunjaya has maintained a broad research interest with publications in both ocular oncology and retinal diseases.
His focus is on multi-modal imaging of ocular tumors and understanding imaging clues that may predict vision loss after ocular radiation therapy. He coordinates multi-center research on the role of genetic testing and outcomes of treatments of ocular melanoma.
In the field of retinal diseases, his interests are in intra-operative imaging to enhance surgical accuracy. -
Julie Muccini, MS, OTR/L
Research Engineer, Rad/Musculoskeletal Imaging
BioJulie Muccini is an occupational therapist who has spent most of her clinical career working with individuals with neurological diagnoses. She is registered and licensed in California and is a member of the American Occupational Therapy Association (AOTA) and the Occupational Therapy Association of California (OTAC). She is actively involved in research working with individuals post-stroke, neuromuscular diseases, and osteoarthritis; additional work includes assessing shoulder movements, sprinting, and balancing tasks; she works in the Human Performance Lab with an interdisciplinary team integrating biomechanics, biomedical engineering, physiology, psychology, and rehabilitation. Ms. Muccini received her bachelor of science in industrial engineering and operations research from the University of Massachusetts at Amherst and her master of science in occupational therapy from Boston University. She started working at the hospital at Stanford in 1997 and transitioned to the Outpatient Neuro Rehab Clinic at the Stanford Neurosciences Health Center in 2014. In March 2021, Julie moved to the Stanford University School of Medicine to work in the Human Performance Lab at the Arrillaga Center for Sports and Recreation, ACSR, as a Wu Tsai Human Performance Alliance member.
-
Mary Beth Mudgett
Senior Associate Dean for the Natural Sciences and Susan B. Ford Professor
Current Research and Scholarly InterestsMy laboratory investigates how bacterial pathogens employ proteins secreted by the type III secretion system (TTSS) to manipulate eukaryotic signaling to promote disease. We study TTSS effectors in the plant pathogen Xanthomonas euvesicatoria, the causal agent of bacterial spot disease of pepper and tomato. For these studies, we apply biochemical, cell biological, and genetic approaches using the natural hosts and model pathosystems.
-
Kunal Mukherjee
Assistant Professor of Materials Science and Engineering
BioKunal Mukherjee is an assistant professor in Materials Science and Engineering at Stanford. He has been an assistant professor in the Materials department at UC Santa Barbara (2016-2020), held postdoctoral appointments at IBM TJ Watson Research Center (2016) and MIT (2015), and worked as a transceiver engineer at Finisar (2009-2010).
The Mukherjee group specializes in semiconductors that emit and detect light in the infrared. Our research enables better materials for data transmission, sensing, manufacturing, and environmental monitoring. We make high-quality thin films with IV-VI (PbSnSe) and III-V (GaAs-InAs/GaSb) material systems and spend much of our time understanding how imperfections in the crystalline structure such as dislocations and point defects impact their electronic and optical properties. This holds the key to directly integrating these semiconductors with silicon and germanium substrates for new hybrid circuits that combine infrared photonics and conventional electronics. -
Ann Mullally
George E. Becker Professor in Medicine
Current Research and Scholarly InterestsDr. Ann Mullally's aboratory studies the genetics, biology and therapy of myeloid blood cancers, with a focus on myeloproliferative neoplasms (MPN). Using primary human samples, mouse models, genomics, single-cell sequencing and CRISPR, as well as cellular and molecular biology, the lab has investigated the key genetic events underlying MPN pathogenesis. Dr. Mullally’s lab elucidated the mechanism by which mutant calreticulin (CALR) is oncogenic and causes MPN.
-
Claudius Mundoma
Director of Shared Instrumentation Facilities, Vice Provost and Dean of Research
Current Role at StanfordDirector of Shared Instrumentation Facilities in the Office of Vice Provost and Dean of Research.
Lead the strategy implementation and evaluation of the Shared Research Platforms initiative -
Rudo Linda Munyengeterwa
Affiliate, FSI
BioLinda Munyengeterwa is IFC’s Global Director of Transaction Advisory - PPPs and Corporate Finance. Her role involves working with teams around the world to design public-private partnerships (PPPs) and collaborate with private sector clients on corporate finance solutions. These activities mobilise private sector capital in developing countries, aiming to deliver tangible impact. The Transaction Advisory team has experience advising governments on designing and bringing to market commercially viable PPPs across various sectors to provide infrastructure and social services to communities. The Transaction Advisory team is on track to deliver nearly $6 billion in private capital mobilisation, contributing 20-25% to IFC’s Core Mobilisation. In FY24, the team delivered $4.9 billion in private capital mobilisation.
Linda became the Global Director in 2022 after serving as the Regional Industry Director (RID) for Africa and Middle East Infrastructure for nearly four years. As RID, she focused on growing IFC’s investment operations and advisory services in energy, transportation, telecommunications, media and technology, mining, and municipal and environmental infrastructure across these regions. During her tenure in Africa, the business grew to over $2bn annually, providing infrastructure access and services to millions.
Before joining IFC, Linda worked as an investment banker in the mergers and acquisition teams of JPMorgan and Fleming Martin. -
Laura Clark Murray
Program Manager for High Impact Technology (HIT) Fund, Office of Technology Licensing (OTL)
BioLaura joined OTL in 2022 to launch the High Impact Technology (HIT) Fund and Program. She has led product marketing management, project management, and operations efforts for Apple, Electronic Arts, and for numerous startups.
-
Mark Musen
Stanford Medicine Professor of Biomedical Informatics Research, Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Jonathan N. Myers
Clinical Professor (Affiliated), Medicine - Med/Cardiovascular Medicine
BioDr. Myers is a Health Research Scientist at the Palo Alto VA Health Care System; a Clinical Professor at Stanford University (Affiliated), and a Senior Research Career Scientist Award recipient through the VA Rehabilitation Research and Development Program. His research has focused on primary and secondary prevention, and the clinical applications of exercise testing and rehabilitation in patients with cardiovascular disease and other chronic conditions. He has a lengthy history of studying the epidemiology of cardiopulmonary exercise test responses, physical activity patterns, and other lifestyle factors and their relation to health outcomes. He manages the Veterans Exercise Testing Study (VETS), an ongoing, prospective evaluation of Veteran subjects referred for exercise testing for clinical reasons, designed to address exercise test, clinical, and lifestyle factors and their association with health outcomes.
He earned his bachelor’s degree from the University of California, Santa Barbara, his master's degree from San Diego State University, and his doctorate from the University of Southern California. He has been a board member for many organizations including the American Heart Association (AHA), the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and the American College of Sports Medicine (ACSM), and serves on the editorial board for 9 journals. He is a recipient of the Michael Pollock Established Investigator Award through the AACVPR, a recipient of the Steven N Blair Award for excellence in physical activity research from the AHA Council on Epidemiology and Prevention and is the 2022 recipient of the American College of Sports Medicine Citation Award. He is a fellow of the AACVPR, ACSM, American College of Cardiology, and the AHA, and has authored and co-authored guidelines on exercise testing and rehabilitation for each of these organizations, including the 2021 editions of the ACSM and AACVPR guidelines. -
David Myung, MD, PhD
Associate Professor of Ophthalmology and, by courtesy, of Chemical Engineering
Current Research and Scholarly InterestsNovel biomaterials to reconstruct the wounded cornea
Mesenchymal stem cell therapy for corneal and ocular surface regeneration
Engineered biomolecule therapies for promote corneal wound healing
Telemedicine in ophthalmology
